Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Suspended 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 10Leukemia 7Hematologic Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms 3Immunoblastic Lymphadenopathy 3Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Pain, Intractable 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Multiple Myeloma 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1

Interventions

Prednisolone 1Methylprednisolone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Neurotoxicity Syndromes × Other hematologic neoplasm × Clear all
NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡